When you buy through links on our articles, Future and its syndication partners may earn a commission.

The PACK trial 1 was a parallel-arm cluster randomised trial, assigning 48 clinics to the intervention arm (a training ...

Walters: They are simple and transparent, eliminate inherent bias and can clearly show whether version A or B of a product ...

Volta Medical put forward new data showing its artificial intelligence-guided ablation procedures were able to improve ...

Semaglutide (Wegovy) may help heavy drinkers cut down on their alcohol intake in addition to losing weight, a trial has found ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

Updated data from the Phase III TALAPRO-2 trial show that the combination of Talzenna (talazoparib) and Xtandi (enzalutamide) significantly improves overall survival in patients with metastatic ...

‘Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial’ by Christian S. Hendershot et al. was published in JAMA Psychiatry at 16:00 UK time on Wednesday 12 February ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Adults with progressive pulmonary fibrosis met the primary endpoint of absolute change in FVC with 52-week oral nerandomilast ...

Researchers at BIDMC found physicians using chatbots spent more time on patient cases and made safer decisions compared to colleagues without AI access.

Clinical decision support (CDS) aimed at reducing overuse of care in seniors does not yield durable changes in terms of ...